All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F21%3A00075224" target="_blank" >RIV/00159816:_____/21:00075224 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064203:_____/21:10428372 RIV/00216208:11130/21:10428372

  • Result on the web

    <a href="https://www.nature.com/articles/s41467-021-22491-8" target="_blank" >https://www.nature.com/articles/s41467-021-22491-8</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1038/s41467-021-22491-8" target="_blank" >10.1038/s41467-021-22491-8</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

  • Original language description

    Genetic discoveries of Alzheimer&apos;s disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n=409,435 and validation size n=58,190). Here, we add six variants associated with Alzheimer&apos;s disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer&apos;s disease patients in APOE 4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer&apos;s disease. Known genetic loci account for only a fraction of the genetic contribution to Alzheimer&apos;s disease. Here, the authors have performed a large genome-wide meta-analysis comprising 409,435 individuals to discover 6 new loci and demonstrate the efficacy of an Alzheimer&apos;s disease polygenic risk score.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10700 - Other natural sciences

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2021

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    NATURE COMMUNICATIONS

  • ISSN

    2041-1723

  • e-ISSN

  • Volume of the periodical

    12

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    16

  • Pages from-to

  • UT code for WoS article

    000713875100002

  • EID of the result in the Scopus database